- Home
- RGR vs PCRX Comparison
RGR vs PCRX Comparison
Compare RGR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- PCRX
- Stock Information
- Founded
- RGR 1949
- PCRX 2006
- Country
- RGR United States
- PCRX United States
- Employees
- RGR N/A
- PCRX N/A
- Industry
- RGR Ordnance And Accessories
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- PCRX Health Care
- Exchange
- RGR Nasdaq
- PCRX Nasdaq
- Market Cap
- RGR 610.8M
- PCRX 604.7M
- IPO Year
- RGR N/A
- PCRX 2011
- Fundamental
- Price
- RGR $35.75
- PCRX $21.03
- Analyst Decision
- RGR
- PCRX Buy
- Analyst Count
- RGR 0
- PCRX 10
- Target Price
- RGR N/A
- PCRX $26.60
- AVG Volume (30 Days)
- RGR 196.4K
- PCRX 754.5K
- Earning Date
- RGR 02-19-2025
- PCRX 02-27-2025
- Dividend Yield
- RGR 1.98%
- PCRX N/A
- EPS Growth
- RGR N/A
- PCRX N/A
- EPS
- RGR 1.73
- PCRX N/A
- Revenue
- RGR $520,485,000.00
- PCRX $694,957,000.00
- Revenue This Year
- RGR N/A
- PCRX $4.94
- Revenue Next Year
- RGR $4.81
- PCRX N/A
- P/E Ratio
- RGR $20.07
- PCRX N/A
- Revenue Growth
- RGR N/A
- PCRX 4.40
- 52 Week Low
- RGR $34.11
- PCRX $11.16
- 52 Week High
- RGR $48.20
- PCRX $34.01
- Technical
- Relative Strength Index (RSI)
- RGR 38.04
- PCRX 66.14
- Support Level
- RGR $34.11
- PCRX $18.18
- Resistance Level
- RGR $35.51
- PCRX $22.36
- Average True Range (ATR)
- RGR 0.68
- PCRX 0.90
- MACD
- RGR 0.11
- PCRX 0.05
- Stochastic Oscillator
- RGR 37.14
- PCRX 62.53
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.